Bone marrow trephine biopsy, Hematoxylin and Eosin stained, evaluated by light microscopy. This histopathology image depicts medullary marrow with cellular admixture dominated by clonal plasma cells. Plasma cells comprise approximately 50% of nucleated cells, demonstrating interstitial (non-follicular) infiltration in a background of residual hematopoietic elements and adipocytes. The architectural pattern is interstitial rather than diffuse sheets at this stage, consistent with stage II myeloma by marrow involvement (Stage II: 20–50% replacement). The plasma cells show hyperchromatic nuclei with clumped chromatin and moderate cytoplasm; occasional binucleation may be present; cytoplasmic features not fully assessable at this magnification. Normal hematopoiesis is variably preserved in focal areas but is increasingly suppressed toward representing marrow replacement. The image correlates with increasing tumor burden and is used for staging, risk assessment, and monitoring response to therapy. In clinical practice, plasmacytosis of this magnitude suggests symptomatic multiple myeloma with potential cytopenias and immunoparesis; cytomorphology must be correlated with flow cytometry and serum/urine studies to confirm clonality. Differential considerations include reactive plasmacytosis, MGUS, and plasmacytoma; however, the extensive involvement and pattern here favor a systemic plasma cell neoplasm. This histology guides prognosis and therapeutic decisions.

Transmission electron microscopy image of bone marrow plasma cells in multiple myeloma, highlighting ultrastructural features of malignant plasmacytosis. The specimen is a bone marrow biopsy/aspirate subjected to TEM to reveal subcellular architecture at high magnification. The primary subject is a plasma cell characterized by a prominent, eccentrically placed nucleus with chunky, irregular clumped chromatin and abundant cytoplasm. Bi- or multinucleation is frequently observed in myeloma cells. The cytoplasm shows extensive rough endoplasmic reticulum organized in parallel lamellae, reflecting heavy immunoglobulin synthesis. Light gray, round to ovoid cytoplasmic inclusions known as Russell bodies are evident within the cytoplasm, representing condensed immunoglobulin within intact endoplasmic reticulum. The cellular borders are well defined, and there is sometimes distension of the ER cisternae near the perinuclear region. The image underscores hallmark features of malignant plasma cells in multiple myeloma and demonstrates both proliferative activity and high secretory load. Clinically, these ultrastructural findings correlate with a high monoclonal immunoglobulin production and marrow infiltration, informing prognosis and therapeutic decisions when integrated with light-chain studies and routine histology. This EM view complements light microscopy by providing evidence of intracellular organelle expansion and intracellular inclusions that are not discernible with conventional staining. Potential educational use includes teaching plasmacytosis, plasma cell neoplasia morphology, and EM-based diagnostic histopathology.

Histology, Light microscopy; bone marrow trephine biopsy stained with Hematoxylin and Eosin (H&E). The specimen shows extensive replacement of normal hematopoietic elements by sheets of immature plasma cells, consistent with marrow involvement by plasma cell myeloma. The infiltrate is markedly cellular with high nuclear-to-cytoplasmic ratio, round to oval nuclei, coarse clumped chromatin, and inconspicuous nucleoli in many cells. Nucleoli are more prominent in a subset of plasma blasts, and some cells display multinucleation. The cytoplasm is variably basophilic and often abundant, contributing to a purple to pink background. The normal marrow architecture is effaced; residual hematopoiesis is sparse. Occasional binucleated or trinucleated plasma cells may be seen; mitotic figures can be present, reflecting active proliferation. The overall pattern is diffuse, with possible focal aggregates. In non-secretory myeloma, as in this case, monoclonal plasma cell proliferation can be demonstrated by immunohistochemistry for kappa or lambda light chains and by molecular studies showing clonal rearrangements, even in the absence of detectable M protein in serum or urine. However, this image itself shows characteristic plasma cell morphology and marrow effacement; clinical correlation with serum free light chains and immunophenotyping is essential for diagnosis and staging. This histopathology supports a diagnosis of multiple myeloma with marrow involvement.

Gross pathology photograph of a spinal vertebral section showing multiple destructive lytic lesions characteristic of plasma cell myeloma involving the axial skeleton. The specimen comprises several contiguous vertebral bodies with preserved posterior elements, oriented in a sagittal plane to expose the cancellous marrow and trabecular bone within. Lesions are red-brown, gelatinous, soft-tissue masses within the vertebral bodies, replacing normal bone marrow and producing conspicuous cortical thinning. The surrounding marrow is dark red and congested, with focal areas of hemorrhagic discoloration. The left side features a centimeter-scale ruler for gross correlation, underscoring the lesion's extent and the degree of vertebral body destruction. Clinically, such lytic vertebral involvement commonly presents with axial bone pain, especially in the back, and may lead to vertebral collapse and potential spinal cord compression. Hypercalcemia from bone resorption can manifest as confusion, weakness, lethargy, constipation, and polyuria. While histology would show sheets of malignant plasma cells with CD138 positivity and light-chain restriction, this gross image emphasizes the destructive bone disease pattern. The image supports radiographic correlation, biopsy planning, and staging assessment in multiple myeloma management. For diagnostic, educational utility, and research applications.

Transmission electron microscopy image of bone marrow plasma cells in multiple myeloma, highlighting ultrastructural features of malignant plasmacytosis. The specimen is a bone marrow biopsy/aspirate subjected to TEM to reveal subcellular architecture at high magnification. The primary subject is a plasma cell characterized by a prominent, eccentrically placed nucleus with chunky, irregular clumped chromatin and abundant cytoplasm. Bi- or multinucleation is frequently observed in myeloma cells. The cytoplasm shows extensive rough endoplasmic reticulum organized in parallel lamellae, reflecting heavy immunoglobulin synthesis. Light gray, round to ovoid cytoplasmic inclusions known as Russell bodies are evident within the cytoplasm, representing condensed immunoglobulin within intact endoplasmic reticulum. The cellular borders are well defined, and there is sometimes distension of the ER cisternae near the perinuclear region. The image underscores hallmark features of malignant plasma cells in multiple myeloma and demonstrates both proliferative activity and high secretory load. Clinically, these ultrastructural findings correlate with a high monoclonal immunoglobulin production and marrow infiltration, informing prognosis and therapeutic decisions when integrated with light-chain studies and routine histology. This EM view complements light microscopy by providing evidence of intracellular organelle expansion and intracellular inclusions that are not discernible with conventional staining. Potential educational use includes teaching plasmacytosis, plasma cell neoplasia morphology, and EM-based diagnostic histopathology.

Imaging modality: light microscopy, bright-field, with hematoxylin and eosin staining of a bone marrow core biopsy. Specimen shows a cellular marrow with sheets of plasma cells occupying a large proportion of the tissue, interrupting normal hematopoietic elements. The malignant plasma cells display classic features of plasma cell neoplasia, including eccentric nuclei and coarse clumped chromatin, and abundant cytoplasm. Within many plasma cells, there are eosinophilic cytoplasmic inclusions representing Russell bodies (immunoglobulin condensations). The distribution is diffuse and sheets are interspersed with residual adipocytes and scattered karyorrhectic debris. The background shows mild interstitial fibrosis and occasional binucleated plasma cells. Notable bystander plasma cells are present but in smaller numbers, consistent with clonal proliferation. In the context of myeloma, such marrow involvement supports a diagnosis of multiple myeloma with heavy plasmacytosis and intracellular immunoglobulin accumulation. Clinically, this morphology prompts ancillary testing including serum protein electrophoresis, immunofixation, and light chain assay to determine monoclonality and disease burden. The image is valuable for educational illustration of Russell bodies in myeloma, differential diagnosis of plasmacytosis, and for correlating histology with cytology and radiology in diagnostic workups. It serves as a reference for hematopathology trainees and pathology education in plasma cell dyscrasias.

Bright-field light microscopy of a bone marrow aspirate cytology smear stained with Wright-Giemsa reveals a plasmacytic infiltrate rich in cytoplasmic inclusions. The primary cells are mature plasma cells with eccentric nuclei and basophilic cytoplasm; numerous cells exhibit cytoplasmic hyaline inclusions known as Russell bodies, which are immunoglobulin-rich vesicular structures derived from rough endoplasmic reticulum. In this field, several cells are markedly vacuolated and, collectively, these may be described as Mott cells when the cytoplasm is packed with multiple Russell bodies. The image also shows some cells with dense, aggregated immunoglobulin droplets and occasional binucleation, reflecting plasmacytic differentiation. Such features can be observed in reactive plasmacytosis as well as in plasma cell neoplasms, including multiple myeloma. Recognition of Russell bodies and Mott cells supports assessment of immunoglobulin synthesis disorders and plasmacytosis burden. The staining highlights cytoplasm more prominently than nuclei, enabling visualization of inclusion bodies and cytoplasmic granularity. Clinically, the presence of Mott cells with Russell bodies raises differential diagnoses that require correlation with serologic studies (Ig levels, monoclonality), marrow clonality assessment, and systemic evaluation for myeloma or gammopathy of undetermined significance. This cytologic pattern is a hallmark of plasmacytic maturation and immunoglobulin handling by malignant or reactive plasma cells.

A pathophysiology diagram illustrating the mechanisms of Myeloma Bone Disease (MBD) and the effects of various pharmacological treatments within the bone marrow microenvironment. The diagram shows the uncoupling of bone remodeling through interactions between myeloma cells, bone marrow stromal cells (BMSCs), osteocytes, osteoblasts, and osteoclasts (OC). Myeloma cells and BMSCs produce osteoclast-activating factors (OAFs) like RANKL, MIP-1α, and TNF-α, which drive osteoclastogenesis and bone resorption. Simultaneously, myeloma cells and osteocytes release osteoblast inhibitory factors (OBIs) such as Dkk-1, sclerostin, and IL-7 to suppress bone formation. Key medical treatments and their targets are annotated: Denosumab (inhibiting RANK-RANKL), Bisphosphonates (inducing OC apoptosis), Scl-ab (inhibiting sclerostin to increase osteoblast differentiation), and Proteasome Inhibitors (PIs) and IMiDs (inhibiting NF-kB and inducing myeloma cell apoptosis). The diagram also highlights the role of sclerostin in increasing bone marrow adipose tissue (BMAT) and Teriparatide in promoting osteoblastogenesis.

This pathophysiology diagram illustrates the extrinsic and intrinsic mechanisms regulating the mTOR signaling pathway in Multiple Myeloma (MM) cells. The 'Extrinsic' panel (left) depicts factors within the bone marrow microenvironment, including hypoxia, osteoblasts, and bone marrow stromal cells (BMSCs). These elements activate mTORC1 through various pathways: cytokine receptors (IL-6R, VEGFR, IGF-1R) stimulating the PI3K/AKT/TSC2/Rheb axis, RANK-RANKL interactions, and G-protein coupled receptor (β2AR) signaling. The 'Intrinsic' panel (right) focuses on cell-autonomous dysregulation, subdivided into aberrant regulator expression and aberrant protein synthesis. Key features include (epi)genetic alterations (RAS mutations, PTEN depletion, RASSF4 silencing), Deptor-mediated activation of mTORC2, and Fbxo9-mediated degradation of Tel2/Tti1. The lower intrinsic section shows how massive protein synthesis induces ER stress and NUPR1, which feeds back to inhibit mTORC1, while downstream eIF4E and MYC reinforce protein synthesis. Symbols indicate phosphorylation, ubiquitination, activation, and inhibition, highlighting the complex crosstalk between microenvironmental stimuli and intracellular genetic mutations in driving oncogenic protein synthesis.

This medical schematic illustrates the components of the Bone Marrow Microenvironment (BMME), specifically in the context of Multiple Myeloma and Innate Lymphoid Cell (ILC) interaction. The diagram is divided into two primary sections: the 'Cellular compartment' and the 'Non-cellular compartment'. The cellular compartment includes bone marrow stromal cells (BMSC), osteoclasts/osteoblasts, t-lymphocytes, and a group consisting of endothelium, fibroblasts, and dendritic cells. The non-cellular compartment includes the extracellular matrix (ECM) and extracellular fluid. Central to the diagram is the BMME acronym, represented by a skeletal icon, indicating its anatomical location. A large bidirectional red arrow depicts a dynamic interaction between the BMME and 'Immune system cells with ILC'. This interaction involves key molecular mediators such as cytokines, adhesion molecules, and metalloproteinases. The figure emphasizes the complex signaling pathways and crosstalk between the bone marrow's structural and immune components that maintain tissue homeostasis or contribute to oncogenic progression in hematologic malignancies.

This pathophysiology diagram illustrates the signaling mechanism by which Multiple Myeloma-derived Extracellular Vesicles (MM-EVs) reprogram the bone marrow microenvironment to promote tumor progression. The central process depicts MM-EVs (yellow circles containing miR-146 and miR-21) acting upon Bone Marrow Mesenchymal Stem Cells (BM-MSCs, shown as tan irregular cells). Initially, normal MSC-EVs (grey circles containing miR-15av) inhibit MM cell growth, maintaining a state of micrometastasis. However, chronic exposure to MM-EVs and the secretion of pro-inflammatory factors (IL6, IL8, CXCL1, CCL2/5, IP-10) transform BM-MSCs into 'CAF-like preconditioned MSCs' (elongated orange cells). These preconditioned cells secrete a specific molecular profile (IL-6, CCL2, Fibronectin, Junction plakoglobin) that drives the transition from a dormant micrometastasis to an active macrometastasis. The diagram emphasizes a shift from tumor growth inhibition to increased MM cell growth, viability, and migration, highlighting the role of EV-mediated communication in cancer metastasis and niche education.